ARTV · Categories · Insider Buys
ARTV - Insider purchases
Artiva Biotherapeutics Inc. (ARTV) insider purchases - real-time wire coverage filtered to Insider Buys only.
Recent Insider Buys for ARTV
- Director Ra Capital Management, L.P. bought $455,726 worth of shares (45,768 units at $9.96) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $412,777 worth of shares (41,319 units at $9.99) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $2,583,314 worth of shares (264,586 units at $9.76) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Amendment: Director Ra Capital Management, L.P. bought $58,307 worth of shares (6,522 units at $8.94) (SEC Form 4)4/A - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $1,432,119 worth of shares (160,354 units at $8.93) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $194,040 worth of shares (21,654 units at $8.96) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $292,126 worth of shares (32,876 units at $8.89) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $4,599,903 worth of shares (531,326 units at $8.66) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $7,650,148 worth of shares (1,027,722 units at $7.44) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Large owner Gc Corp. bought $16,499,992 worth of shares (1,432,291 units at $11.52) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. bought $74,999,992 worth of shares (6,510,416 units at $11.52) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Ra Capital Management, L.P. converted options into 1,058,282 shares, acquired $4,709,207 worth of shares (461,687 units at $10.20) and bought $99,999,996 worth of shares (8,333,333 units at $12.00) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Large owner 5am Partners Vi, Llc converted options into 1,058,284 shares, acquired $4,709,207 worth of shares (461,687 units at $10.20) and bought $9,999,996 worth of shares (833,333 units at $12.00) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Large owner Venbio Global Strategic Fund Iii, L.P. bought $4,999,992 worth of shares (416,666 units at $12.00), converted options into 1,058,284 shares and acquired 461,687 shares (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Large owner Gc Corp. converted options into 1,352,252 shares, acquired $5,614,417 worth of shares (550,433 units at $10.20) and bought $24,999,984 worth of shares (2,083,332 units at $12.00) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)
- Director Huh Yong-Jun bought $24,999,984 worth of shares (2,083,332 units at $12.00), converted options into 1,352,252 shares and acquired $5,614,417 worth of shares (550,433 units at $10.20) (SEC Form 4)4 - Artiva Biotherapeutics, Inc. (0001817241) (Issuer)